Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
7 December 2015 |
Main ID: |
NCT01880619 |
Date of registration:
|
13/06/2013 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Comparison of Tamsulosin and Solifenacin in Treatment of Ureteral Stent Symptoms
|
Scientific title:
|
A Randomized Clinical Trial Comparing Alpha Blacker (Tamsulosin) and Anticholinergic (Solifenacin) in Treatment of Ureteral Stent Related Symptoms |
Date of first enrolment:
|
January 2013 |
Target sample size:
|
131 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01880619 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
|
Phase:
|
Phase 4
|
|
Countries of recruitment
|
Egypt
| | | | | | | |
Contacts
|
Name:
|
Ahmed R EL-Nahas, A. Professor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Urology and Nephrology Center, Mansoura University |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
Patient who will undergo unilateral ureteral stent fixation:
1. To relieve upper urinary tract obstruction caused by ureteric calculi
2. After ureteroscopic lithotripsy for ureteral calculi.
Exclusion Criteria:
1. Patients who had LUTS before stent fixation.
2. Ureteral stent fixation after open or laparoscopic surgery.
3. Bilateral ureteral stents.
4. Patients who developed complications related to the primary endoscopic procedure
5. Patients who developed stent related complications such as hematuria, acute
pyelonephritis or stent displacement
Age minimum:
20 Years
Age maximum:
50 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Relieve of Ureteral Stent Symptoms
|
Intervention(s)
|
Drug: Control
|
Drug: Solifenacin
|
Drug: Tamsulosin
|
Primary Outcome(s)
|
The Efficacy of tamsulosin and solifenacin in relieving ureteral stent symptoms will be evaluated by comparing the scores of ureteral stent symptoms questionnaire in the studied groups
[Time Frame: 1 year]
|
Secondary ID(s)
|
Treatment of USS
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|